Gender Disparities in Statin Prescriptions in People With HIV With Low/Moderate to High Cardiovascular Risk

The REPRIEVE trial suggests that primary cardiovascular disease (CVD) prevention could be considered among people with HIV at low CVD risk. We found cisgender women with low/moderate and high CVD risk are less likely to receive statins than cisgender men. Efforts are needed to guarantee equal access to statin-based CVD prevention.

Authors

Institutions

Publication Details

Journal
Open Forum Infectious Diseases
Published
2024-08-30
DOI
https://doi.org/10.1093/ofid/ofae502
Citations
2
Primary Topic
HIV-related health complications and treatments
Type
article
Field-Weighted Citation Impact
1.38

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Gender Disparities in Statin Prescriptions in People With HIV With Low/Moderate to High Cardiovascular Risk

PHILIP E. TARR, Enos Bernasconi, Dunja Nicca, Giuseppe Pantaleo et al.
2 citations
Open Forum Infectious Diseases
HIV-related health complications and treatments
1.38
article

Gender Disparities in Statin Prescriptions in People With HIV With Low/Moderate to High Cardiovascular Risk

PHILIP E. TARR, Enos Bernasconi, Dunja Nicca, Giuseppe Pantaleo, Niklaus Daniel Labhardt, Matthias L. Cavassini, Olivia Keiser, Angela Ciuffi, G Dollenmaier, Heiner C. Bucher, Hans Hellmuth Hirsch, Sabine Yerly, Johannes Nemeth, Karoline Aebi‐Popp, Maja Weisser, Alain Amstutz, Bernard Surial, Gilles Wandeler, Irène A. Abela, Helen Kovari, David Jackson‐Perry, Anna Hachfeld, P Paioni, M Cavassini, Begoña Martínez de Tejada, Catia Marzolini, Karin J. Metzner, Luisa Salazar‐Vizcaya, Thomas Klimkait, Marcel Stoeckle, Marie Ballif, Chloé Pasin, Angelika Rauch, Huldrych F. Günthard, Frédérique Chammartin, Karoline Leuzinger, Roger D. Kouyos, Julia Notter, Matthias Egger, René Speck, Olivier Ségéral, C A Fux, Dominique L. Braun, Jacques Fellay, A Anagnostopoulos, N Müller, Patrick Schmid, H Furrer, C R Kahlert, A Calmy, B Hassec, L Elzi, J Fehr, A Trkola, M Perreau, M Battegay, M Huber, M Stöckle, Irène Hösli, Matthew Hoffmann, David Haerry, K Kusejko
article en
2 citations

Abstract

The REPRIEVE trial suggests that primary cardiovascular disease (CVD) prevention could be considered among people with HIV at low CVD risk. We found cisgender women with low/moderate and high CVD risk are less likely to receive statins than cisgender men. Efforts are needed to guarantee equal access to statin-based CVD prevention.

Open Forum Infectious DiseasesVol. 11(9)
University of Geneva (CH), University of Bern (CH), Oslo University Hospital (NO), University of Oslo (NO), University of Basel (CH), University of Zurich (CH), University of St.Gallen (CH), University Hospital of Bern (CH), University Hospital of Basel (CH), University of Bristol (GB), Ente Ospedaliero Cantonale (CH), University Hospital of Zurich (CH), Institute of Social and Preventive Medicine (CH), University of Lausanne (CH)
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung, Universität Zürich, Swiss HIV Cohort Research Foundation, Stanford Humanities Center, Stanford University
Gender equality
Openalex Percentile: Top 18%
HIV-related health complications and treatments
1.38
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.